Filter
2831
Text search:
medicines
safety
Featured
Recommendations
339
New Publications
786
Language
Document type
No document type
1329
Guidelines
510
Studies & Reports
471
Manuals
196
Strategic & Response Plan
154
Fact sheets
62
Training Material
43
Situation Updates
33
Resource Platforms
11
Brochures
10
Infographics
6
Online Courses
4
Videos
2
Countries / Regions
Global
119
India
107
Kenya
91
South Africa
75
Ethiopia
70
Uganda
63
Liberia
58
Nigeria
57
Sierra Leone
55
Western and Central Europe
52
Nepal
47
Tanzania
45
Myanmar / Burma
45
Bangladesh
44
Ghana
43
Zambia
42
Africa
40
Malawi
38
Latin America and the Carribbean
37
Namibia
34
Ukraine
34
Syria
30
Rwanda
30
Congo, Democratic Republic of
27
Philippines
25
South–East Asia Region
21
Eastern Europe
19
Asia
18
Zimbabwe
17
Guinea
16
Haiti
14
South Sudan
14
Cambodia
13
Indonesia
13
Lesotho
13
Middle East and North Africa
13
West and Central Africa
12
Eastern Europe and Central Asia
12
Pakistan
11
Brazil
11
Mozambique
10
Botswana
10
Yemen
10
Russia
10
Afghanistan
9
Sudan
9
East and Southern Africa
9
Venezuela
9
Vietnam
8
Burkina Faso
7
Cameroon
7
Somalia
7
Thailand
7
Eswatini/ Swaziland
7
Senegal
6
Germany
6
Lebanon
6
Western Pacific Region
6
Laos
6
Moldova
6
Central African Republic
5
Iraq
4
Jordan
4
Peru
4
Colombia
4
Libya
4
Madagascar
4
Bhutan
4
Tajikistan
4
United Kingdom
4
Mali
3
China
3
Argentina
3
North Macedonia
3
Sri Lanka
3
Poland
3
Palestine
3
Albania
3
Georgia
3
North America
3
Mauritius
3
Côte d’Ivoire / Ivory Coast
2
USA
2
Saudi Arabia
2
Turkey
2
Egypt
2
Papua New Guinea
2
Switzerland
2
Ecuador
2
El Salvador
2
Bolivia
2
Angola
2
Chile
2
Southern Africa
2
Timor Leste/ East Timor
2
Qatar
2
Romania
2
Iran
2
Gabon
2
Turkmenistan
2
Guinea-Bissau
1
Morocco
1
Niger
1
Togo
1
Chad
1
Gambia
1
Benin
1
Serbia
1
Hungary
1
Burundi
1
Mexico
1
Paraguay
1
Fiji
1
Djibouti
1
Armenia
1
Canada
1
Bulgaria
1
Lithuania
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Japan
1
Denmark
1
Maldives
1
Tunisia
1
Belarus
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1104
Clinical Guidelines
284
Public Health
174
Women & Child Health
135
Key Resources
130
Pharmacy & Technologies
41
Capacity Building
40
Toolboxes
COVID-19
252
HIV
202
AMR
196
Pharmacy
164
TB
151
Mental Health
150
Caregiver
83
NTDs
77
Conflict
76
Ebola & Marburg
70
Planetary Health
58
Disability
57
NCDs
57
Rapid Response
46
Global Health Education
46
Malaria
46
Refugee
45
Natural Hazards
35
2.0 Rapid Response
19
Health Financing Toolbox
18
Zika
13
Cholera
7
Specific Hazards
7
Polio
6
Social Ethics
3
The Bolivarian Republic of Venezuela has been facing a prolonged socio-political and economic situation that has profoundly and negatively impacted social and health indicators. The COVID-19 pandemic further aggravated the humanitarian context in the
country, which stretched the limits of an alread
...
Усиление мер реагирования систем здравоохранения на COVID-19: техническое руководство № 2
recommended
Обеспечение возможностей быстрого развертывания сил и средств для оказания неотложной помощи и интенсивного лечения (6 апреля 2020 г.)
Главный вопрос, рассматривае
...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202
...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
A recent study informed that ivermectin was successfully used in vitro for the treatment of SARS-CoV-2 in experimentally infected cells and two preprint publications on observational clinical studies reported the apparent utility of ivermectin to treat patients with COVID-19 needing mechanical venti
...
Bangladesh Health Systems in Transition
This article is part four in a series of explainers on vaccine development and distribution
Available in different languages
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.